These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24632699

  • 1. Macrophage activation syndrome in Kawasaki disease.
    Mukherjee D, Pal P, Kundu R, Niyogi P.
    Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
    [Abstract] [Full Text] [Related]

  • 2. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
    J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
    [Abstract] [Full Text] [Related]

  • 3. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC, Vincenti M, Darras JP, Lalande M, Rodière M, Filleron A.
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [Abstract] [Full Text] [Related]

  • 4. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I, Prabhu SS.
    Ann Trop Paediatr; 2009 Mar; 29(1):51-3. PubMed ID: 19222935
    [Abstract] [Full Text] [Related]

  • 5. Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease.
    Rivera-Rodriguez L, Pardo-Díaz E, Moreno-Espinosa S, Scheffler-Mendoza S, Ruiz-Ontiveros MA, Garrido-García LM, Iglesias-Amaya A, Yamazaki-Nakashimada MA.
    J Pediatr Hematol Oncol; 2021 Apr 01; 43(3):e448-e451. PubMed ID: 32079989
    [Abstract] [Full Text] [Related]

  • 6. A 5-year-old boy with Kawasaki disease shock syndrome, myocarditis and macrophage activation syndrome.
    Pilania RK, Arora K, Gupta A, Vignesh P, Suri D, Singh S.
    J Paediatr Child Health; 2021 Aug 01; 57(8):1312-1315. PubMed ID: 32924231
    [No Abstract] [Full Text] [Related]

  • 7. Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: success with pulse steroid therapy.
    Shetty AK, Homsi O, Ward K, Gedalia A.
    J Rheumatol; 1998 Jun 01; 25(6):1215-7. PubMed ID: 9632089
    [Abstract] [Full Text] [Related]

  • 8. Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches.
    Han SB, Lee SY.
    World J Pediatr; 2020 Dec 01; 16(6):566-574. PubMed ID: 32418074
    [Abstract] [Full Text] [Related]

  • 9. Resistant Kawasaki disease.
    Nachiappan J, May M, Hawker RE, Hong P.
    J Paediatr Child Health; 2004 Dec 01; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract] [Full Text] [Related]

  • 10. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Pilania RK, Jindal AK, Johnson N, Prithvi A, Vignesh P, Suri D, Rawat A, Gupta A, Singh S.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):3413-3419. PubMed ID: 33221920
    [Abstract] [Full Text] [Related]

  • 11. [Kawasaki disease complicated by autoimmune hemolytic anemia and macrophage activation syndrome: a case report].
    Liu RH, Liu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep 01; 11(9):778-9. PubMed ID: 19755036
    [No Abstract] [Full Text] [Related]

  • 12. Macrophage activation syndrome in the acute phase of Kawasaki disease.
    Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    J Pediatr Hematol Oncol; 2010 Oct 01; 32(7):527-31. PubMed ID: 20485197
    [Abstract] [Full Text] [Related]

  • 13. Kawasaki disease and alopecia areata: coincidence or a true association?
    Krishnamurthy S, Chandrashekar L, Mondal N.
    Pediatr Dermatol; 2012 Oct 01; 29(4):532-4. PubMed ID: 21906152
    [Abstract] [Full Text] [Related]

  • 14. Macrophage activation syndrome: a rare complication of incomplete Kawasaki disease.
    Suresh N, Sankar J.
    Ann Trop Paediatr; 2010 Oct 01; 30(1):61-4. PubMed ID: 20196936
    [Abstract] [Full Text] [Related]

  • 15. [Macrophage activation syndrome and Kawasaki disease: Four new cases].
    Dumont B, Jeannoel P, Trapes L, Rolland E, Gay C, Stephan JL.
    Arch Pediatr; 2017 Jul 01; 24(7):640-646. PubMed ID: 28583781
    [Abstract] [Full Text] [Related]

  • 16. Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease.
    Dahlem PG, von Rosenstiel IA, Lam J, Kuijpers TW.
    Intensive Care Med; 1999 Oct 01; 25(10):1137-9. PubMed ID: 10551972
    [Abstract] [Full Text] [Related]

  • 17. Hair loss as a sign of Kawasaki disease.
    Nabavizadeh SH, Safari M, Amin R.
    Iran J Allergy Asthma Immunol; 2006 Dec 01; 5(4):199-200. PubMed ID: 17237574
    [Abstract] [Full Text] [Related]

  • 18. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr 01; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 19. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.
    Lind-Holst M, Hartling UB, Christensen AE.
    BMJ Case Rep; 2019 Aug 04; 12(8):. PubMed ID: 31383678
    [Abstract] [Full Text] [Related]

  • 20. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 04; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.